Emerald Health Therapeutics Inc
F:TBD
Income Statement
Earnings Waterfall
Emerald Health Therapeutics Inc
Income Statement
Emerald Health Therapeutics Inc
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue |
13
N/A
|
12
-10%
|
11
-5%
|
14
+25%
|
13
-9%
|
12
-6%
|
12
-3%
|
7
-39%
|
|
| Gross Profit | |||||||||
| Cost of Revenue |
(28)
|
(24)
|
(22)
|
(25)
|
(21)
|
(17)
|
(16)
|
(11)
|
|
| Gross Profit |
(15)
N/A
|
(12)
+19%
|
(11)
+9%
|
(11)
-5%
|
(9)
+23%
|
(5)
+44%
|
(5)
+7%
|
(4)
+15%
|
|
| Operating Income | |||||||||
| Operating Expenses |
(19)
|
(17)
|
(15)
|
(19)
|
(19)
|
(18)
|
(18)
|
(12)
|
|
| Selling, General & Administrative |
(15)
|
(14)
|
(12)
|
(15)
|
(15)
|
(14)
|
(14)
|
(11)
|
|
| Research & Development |
0
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
0
|
|
| Depreciation & Amortization |
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(34)
N/A
|
(29)
+14%
|
(26)
+11%
|
(31)
-18%
|
(27)
+10%
|
(23)
+18%
|
(22)
+3%
|
(16)
+27%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
2
|
(0)
|
(3)
|
0
|
2
|
1
|
(0)
|
(3)
|
|
| Non-Reccuring Items |
(87)
|
(14)
|
(12)
|
(9)
|
(11)
|
(23)
|
(23)
|
(9)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(3)
|
|
| Total Other Income |
(7)
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
|
| Pre-Tax Income |
(126)
N/A
|
(43)
+66%
|
(41)
+5%
|
(39)
+5%
|
(37)
+6%
|
(42)
-14%
|
(43)
-2%
|
(28)
+35%
|
|
| Net Income | |||||||||
| Tax Provision |
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(126)
|
(44)
|
(42)
|
(39)
|
(37)
|
(42)
|
(43)
|
(28)
|
|
| Income to Minority Interest |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(125)
N/A
|
(43)
+66%
|
(41)
+4%
|
(39)
+5%
|
(37)
+6%
|
(42)
-14%
|
(43)
-2%
|
(28)
+35%
|
|
| EPS (Diluted) |
-0.65
N/A
|
-0.2
+69%
|
-0.19
+5%
|
-0.18
+5%
|
-0.17
+6%
|
-0.2
-18%
|
-0.2
N/A
|
-0.13
+35%
|
|